ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 27 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $40,467 | -48.8% | 194,364 | -13.9% | 0.00% | – |
| Q1 2023 | $79,050 | +63.6% | 225,855 | +0.5% | 0.00% | – |
| Q4 2022 | $48,315 | -38.8% | 224,721 | +0.3% | 0.00% | – |
| Q3 2022 | $79,000 | -73.8% | 223,965 | -0.4% | 0.00% | – |
| Q2 2022 | $301,000 | -33.7% | 224,910 | -0.3% | 0.00% | – |
| Q1 2022 | $454,000 | -25.9% | 225,477 | -0.7% | 0.00% | – |
| Q4 2021 | $613,000 | -26.8% | 227,178 | +16.3% | 0.00% | – |
| Q3 2021 | $837,000 | +67.7% | 195,255 | -0.3% | 0.00% | – |
| Q2 2021 | $499,000 | +0.2% | 195,911 | -4.8% | 0.00% | – |
| Q1 2021 | $498,000 | +42.3% | 205,684 | 0.0% | 0.00% | – |
| Q4 2020 | $350,000 | -23.7% | 205,684 | 0.0% | 0.00% | – |
| Q3 2020 | $459,000 | +60.5% | 205,684 | 0.0% | 0.00% | – |
| Q2 2020 | $286,000 | +7.1% | 205,684 | 0.0% | 0.00% | – |
| Q1 2020 | $267,000 | -46.2% | 205,684 | 0.0% | 0.00% | – |
| Q4 2019 | $496,000 | +59.5% | 205,684 | 0.0% | 0.00% | – |
| Q3 2019 | $311,000 | -10.1% | 205,684 | 0.0% | 0.00% | – |
| Q2 2019 | $346,000 | -50.9% | 205,684 | 0.0% | 0.00% | – |
| Q1 2019 | $705,000 | -33.0% | 205,684 | 0.0% | 0.00% | – |
| Q4 2018 | $1,053,000 | – | 205,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|